The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

The Medicare $2 Drug List Model included generic drugs for high blood pressure, diabetes and other ailments many elderly face ...

There is not a single member of AAM who has not raised concerns about the tariff situation,” said the CEO of the generic drug ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...